A soy-based phosphatidylserine/ phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: a randomized, placebo-controlled study

Table 1 Baseline measures

	Age [years]	Height [m]	Body mass [kg]	BMI [kg/m²]	WHR	Systolic blood pressure [mmHG]	Diastolic blood pressure [mmHG]	Heart rate [bpm]
Placebo group
Mean	26.64	1.81	83.68	25.45	0.86	127.64	71.08	69.16
SE	1.48	0.02	2.26	0.56	0.01	2.08	1.64	1.89
N	25	25	25	25	24	25	25	25
PAS 200 group
Mean	25.92	1.82	84.8	25.59	0.86	131.68	73.64	73.32
SE	1.32	0.02	3.11	0.73	0.01	1.5	2.11	2.49
N	25	25	25	25	25	25	25	25
PAS 400 group
Mean	26.48	1.83	85.2	25.59	0.87	129.12	73.56	71.2
SE	1.37	0.01	2.32	0.8	0.01	2.52	2.39	2.84
N	25	25	25	25	25	25	25	25
Group differences ^a
χ²	0.077	0.250	0.684	0.252	0.550	2,717	1,011	1,758
df	2	2	2	2	2	2	2	2
p	0.962	0.882	0.711	0.882	0.760	0.257	0.603	0.415

^abased on Kruskal Wallis H test.
PAS 200 group: 200 mg PA & 200 mg PS per day; PAS 400 group: 400 mg PA & 400 mg PS per day.
PA = phosphatidic acid, PS = phosphatidylserine, mg = milligrams, m = meter, kg = kilograms, mmHG = millimeter of mercury, bpm = beats per minute, SE = Standard Error, N = Sample Size.

ISSN: 1476-511X